Advertisement

Journal of General Internal Medicine

, Volume 34, Issue 11, pp 2652–2659 | Cite as

Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial

  • Tannaz MoinEmail author
  • O. Kenrik Duru
  • Norman Turk
  • Janet S. Chon
  • Dominick L. Frosch
  • Jacqueline M. Martin
  • Kia Skrine Jeffers
  • Yelba Castellon-Lopez
  • Chi-Hong Tseng
  • Keith Norris
  • Carol M. Mangione
Health Policy

Abstract

Importance

Intensive lifestyle change (e.g., the Diabetes Prevention Program) and metformin reduce type 2 diabetes risk among patients with prediabetes. However, real-world uptake remains low. Shared decision-making (SDM) may increase awareness and help patients select and follow through with informed options for diabetes prevention that are aligned with their preferences.

Objective

To test the effectiveness of a prediabetes SDM intervention.

Design

Cluster randomized controlled trial.

Setting

Twenty primary care clinics within a large regional health system.

Participants

Overweight/obese adults with prediabetes (BMI ≥ 24 kg/m2 and HbA1c 5.7–6.4%) were enrolled from 10 SDM intervention clinics. Propensity score matching was used to identify control patients from 10 usual care clinics.

Intervention

Intervention clinic patients were invited to participate in a face-to-face SDM visit with a pharmacist who used a decision aid (DA) to describe prediabetes and four possible options for diabetes prevention: DPP, DPP ± metformin, metformin only, or usual care.

Main Outcomes and Measures

Primary endpoint was uptake of DPP (≥ 9 sessions), metformin, or both strategies at 4 months. Secondary endpoint was weight change (lbs.) at 12 months.

Results

Uptake of DPP and/or metformin was higher among SDM participants (n = 351) than controls receiving usual care (n = 1028; 38% vs. 2%, p < .001). At 12-month follow-up, adjusted weight loss (lbs.) was greater among SDM participants than controls (− 5.3 vs. − 0.2, p < .001).

Limitations

Absence of DPP supplier participation data for matched patients in usual care clinics.

Conclusions and Relevance

A prediabetes SDM intervention led by pharmacists increased patient engagement in evidence-based options for diabetes prevention and was associated with significantly greater uptake of DPP and/or metformin at 4 months and weight loss at 12 months. Prediabetes SDM may be a promising approach to enhance prevention efforts among patients at increased risk.

Trial Registration

This study was registered at clinicaltrails.gov (NCT02384109)).

KEY WORDS

shared decision-making diabetes mellitus 

Notes

Acknowledgments

The authors would like to thank Mr. RM for his help with project coordination, Mr. SL for help with data acquisition, and Ms. KS, Ms. SS, Dr. WS, and Ms. MK for their help with DPP implementation/delivery. The authors would also like to thank Drs. SLE and GM for their input throughout the trial. The authors would also like to thank Healthwise for providing the DA at no cost to the study and Dr. MB for facilitating the collaboration. The authors would also like to thank all the clinics, providers, and patients who made this study possible.

Funders

This study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (R18DK105464). Dr. Moin also receives support from the Department of Veterans Affairs (QUE15-272, QUE15-286, and CSP2002). Dr. Mangione receives support from the University of California at Los Angeles (UCLA), Resource Centers for Minority Aging Research Center for Health Improvement of Minority Elderly under National Institutes of Health (NIH)/NIA Grant P30-AG021684, and from NIH/National Center for Advancing Translational Sciences UCLA Clinical and Translational Science Institute Grant UL1TR000124. Dr. Mangione holds the Barbara A. Levey and Gerald S. Levey Endowed Chair in Medicine, which partially supported her work. Drs. Duru’s effort is also supported in part by the University of California, Los Angeles, Resource Center for Minority Aging Research, Center for Health Improvement of Minority Elderly (RCMAR/CHIME) under NIH/NIA Grant P30-AG021684 and NIH Career Development Award K08-AG033360. Dr. Mangione is a member of the U.S. Preventive Services Task Force.

Compliance with Ethical Standards

The study was approved by the Institutional Review Board at the University of California, Los Angeles. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflict of Interest

Dr. Duru is on the Healthwise scientific board. None of the other authors disclosed any potential conflicts of interest.

Disclaimer

The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the views of the National Institutes of Health (NIH) and the US Preventive Services Task Force.

References

  1. 1.
    Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361–7. doi: https://doi.org/10.1007/s11606-012-2077-6 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Elwyn G, Laitner S, Coulter A, Walker E, Watson P, Thomson R. Implementing shared decision making in the NHS. BMJ. 2010;341:c5146. doi: https://doi.org/10.1136/bmj.c5146 CrossRefPubMedGoogle Scholar
  3. 3.
    Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011(10):CD001431. doi: https://doi.org/10.1002/14651858.CD001431.pub3 CrossRefGoogle Scholar
  4. 4.
    Mullan RJ, Montori VM, Shah ND, Christianson TJ, Bryant SC, Guyatt GH, et al. The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med. 2009;169(17):1560–8. doi: https://doi.org/10.1001/archinternmed.2009.293 [doi]CrossRefGoogle Scholar
  5. 5.
    Institute of Medicine. 2001. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington: The National Academies Press. https://www.nap.edu/catalog/10027/crossing-the-quality-chasm-a-new-health-system-for-the Accessed May 15, 2019.Google Scholar
  6. 6.
    Oshima Lee E, Emanuel EJ. Shared decision making to improve care and reduce costs. N Engl J Med. 2013;368(1):6–8. doi: https://doi.org/10.1056/NEJMp1209500 CrossRefPubMedGoogle Scholar
  7. 7.
    Allen JD, Akinyemi IC, Reich A, Fleary S, Tendulkar S, Lamour N. African American Women’s Involvement in Promoting Informed Decision-Making for Prostate Cancer Screening Among Their Partners/Spouses. Am J Mens Health. 2018;12(4):884–93. doi: https://doi.org/10.1177/1557988317742257 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Kane HL, Halpern MT, Squiers LB, Treiman KA, McCormack LA. Implementing and evaluating shared decision making in oncology practice. CA Cancer J Clin. 2014;64(6):377–88. doi: https://doi.org/10.3322/caac.21245 CrossRefPubMedGoogle Scholar
  9. 9.
    Ankuda CK, Block SD, Cooper Z, Correll DJ, Hepner DL, Lasic M, et al. Measuring critical deficits in shared decision making before elective surgery. Patient Educ Couns. 2014;94(3):328–33. doi: https://doi.org/10.1016/j.pec.2013.11.013 CrossRefPubMedGoogle Scholar
  10. 10.
    Kattan M, ed. Encyclopedia of medical decision making. SAGE Publications; 2009.Google Scholar
  11. 11.
    Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. doi: https://doi.org/10.1056/NEJMoa012512 CrossRefPubMedGoogle Scholar
  12. 12.
    Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677–86. doi: https://doi.org/10.1016/S0140-6736(09)61457-4 CrossRefPubMedCentralGoogle Scholar
  13. 13.
    Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3(11):866–75. doi: https://doi.org/10.1016/S2213-8587(15)00291-0 CrossRefPubMedCentralGoogle Scholar
  14. 14.
    American Diabetes Association. Standards of medical care in diabetes--2016. Diabetes Care. 2016;39 Suppl 1:S1–112.Google Scholar
  15. 15.
    Diabetes Prevention Program Research Group. HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial. Diabetes Care. 2015;38(1):51–8. doi: https://doi.org/10.2337/dc14-0886 CrossRefGoogle Scholar
  16. 16.
    Diabetes Prevention Program Research Group. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2012;35(4):731–7. doi: https://doi.org/10.2337/dc11-1299 CrossRefGoogle Scholar
  17. 17.
    Herman WH, Edelstein SL, Ratner RE, Montez MG, Ackermann RT, Orchard TJ, et al. Effectiveness and cost-effectiveness of diabetes prevention among adherent participants. Am J Manag Care. 2013;19(3):194–202.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 2012;35(4):723–30. doi: https://doi.org/10.2337/dc11-1468 CrossRefGoogle Scholar
  19. 19.
    Centers for Disease Ccontrol and Prevention. Awareness of prediabetes--United States, 2005–2010. MMWR Morb Mortal Wkly Rep. 2013;62(11):209–12.Google Scholar
  20. 20.
    Gopalan A, Lorincz IS, Wirtalla C, Marcus SC, Long JA. Awareness of Prediabetes and Engagement in Diabetes Risk-Reducing Behaviors. Am J Prev Med. 2015;49(4):512–9. doi: https://doi.org/10.1016/j.amepre.2015.03.007 CrossRefPubMedGoogle Scholar
  21. 21.
    The Ottawa Hospital Research Institute. Patient Decision Aids: Decision Aid Summary. http://decisionaid.ohri.ca/Azsumm.php? ID=1654. Accessed May 15, 2019.
  22. 22.
    FDA. Drug Safety Communications. 2016. http://www.fda.gov/downloads/Drugs/DrugSafety/UCM494140.pdf. Accessed Accessed May 15, 2019.
  23. 23.
    Moin T, Li J, Duru OK, Ettner S, Turk N, Keckhafer A, et al. Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study. Ann Intern Med. 2015;162(8):542–8. doi: https://doi.org/10.7326/M14-1773 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Little RJ, Wang Y. Pattern-mixture models for multivariate incomplete data with covariates. Biometrics. 1996;52(1):98–111.CrossRefGoogle Scholar
  25. 25.
    Ratitch B, O’Kelly M, Tosiello R. Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models. Pharm Stat. 2013;12(6):337–47. doi: https://doi.org/10.1002/pst.1549 CrossRefPubMedGoogle Scholar
  26. 26.
    Wu S, Crespi CM, Wong WK. Comparison of methods for estimating the intraclass correlation coefficient for binary responses in cancer prevention cluster randomized trials. Contemp Clin Trials. 2012;33(5):869–80. doi: https://doi.org/10.1016/j.cct.2012.05.004 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Ely EK, Gruss SM, Luman ET, Gregg EW, Ali MK, Nhim K, Rolka DB, Albright AL. A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC’s National Diabetes Prevention Program. Diabetes Care. 2017;4010.Google Scholar
  28. 28.
    Aziz Z, Absetz P, Oldroyd J, Pronk NP, Oldenburg B. A systematic review of real-world diabetes prevention programs: learnings from the last 15 years. Implement Sci :IS. 2015;10:172. doi: https://doi.org/10.1186/s13012-015-0354-6
  29. 29.
    Moin T, Schmittdiel JA, Flory JH, Yeh J, Karter AJ, Kruge LE, Schillinger D, Mangione CM, Herman WH, Walker EA. Review of Metformin Use for Type 2 Diabetes Prevention. Am J Prev Med. 2018 Oct;55(4):565–574. doi:  https://doi.org/10.1016/j.amepre.2018.04.038.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29(9):2102–7. doi: https://doi.org/10.2337/dc06-0560 CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Bauer AM, Parker MM, Schillinger D, Katon W, Adler N, Adams AS, et al. Associations between antidepressant adherence and shared decision-making, patient-provider trust, and communication among adults with diabetes: diabetes study of Northern California (DISTANCE). J Gen Intern Med. 2014;29(8):1139–47. doi: https://doi.org/10.1007/s11606-014-2845-6 CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    O’Brien MJ, Moran MR, Tang JW, Vargas MC, Talen M, Zimmermann LJ, et al. Patient Perceptions About Prediabetes and Preferences for Diabetes Prevention. Diabetes Educ. 2016;42(6):667–77. doi: https://doi.org/10.1177/0145721716666678 CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Mainous AG 3rd, Tanner RJ, Baker R. Prediabetes Diagnosis and Treatment in Primary Care. Journal of the American Board of Family Medicine. J Am Board Fam Med. 2016;29(2):283–5. doi: https://doi.org/10.3122/jabfm.2016.02.150252 CrossRefPubMedGoogle Scholar
  34. 34.
    Marshall C, Adams S, Dyer W, Schmittdiel J. Opportunities to Reduce Diabetes Risk in Women of Reproductive Age: Assessment and Treatment of Prediabetes within a Large Integrated Delivery System. Womens Health Issues. 2017;27(6):666–72. doi: https://doi.org/10.1016/j.whi.2017.06.001 CrossRefPubMedGoogle Scholar
  35. 35.
    Katon W, Von Korff M, Lin E, Simon G. Rethinking practitioner roles in chronic illness: the specialist, primary care physician, and the practice nurse. Gen Hosp Psychiatry. 2001;23(3):138–44.CrossRefGoogle Scholar
  36. 36.
    Willard-Grace R, Chen EH, Hessler D, DeVore D, Prado C, Bodenheimer T, et al. Health coaching by medical assistants to improve control of diabetes, hypertension, and hyperlipidemia in low-income patients: a randomized controlled trial. Ann Fam Med. 2015;13(2):130–8. doi: https://doi.org/10.1370/afm.1768 CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Celeste-Harris S, Maryniuk M. Educating Medical Office Staff: Enhancing Diabetes Care in Primary Care Offices. Diabetes Spectr. 2006;19(2):84–9.CrossRefGoogle Scholar
  38. 38.
    Cranor CW, Christensen DB. The Asheville Project: Short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (2003). 2012;52(6):838–50.  https://doi.org/10.1331/JAPhA.2012.12542 CrossRefGoogle Scholar
  39. 39.
    Smith M, Bates DW, Bodenheimer TS. Pharmacists belong in accountable care organizations and integrated care teams. Health Aff (Millwood). 2013;32(11):1963–70.  https://doi.org/10.1377/hlthaff.2013.0542 CrossRefGoogle Scholar
  40. 40.
    Weber CA, Ernst ME, Sezate GS, Zheng S, Carter BL. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med. 2010;170(18):1634–9. doi: https://doi.org/10.1001/archinternmed.2010.349 CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Hirsch JD, Steers N, Adler DS, Kuo GM, Morello CM, Lang M, et al. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. Clin Ther. 2014;36(9):1244–54. doi: https://doi.org/10.1016/j.clinthera.2014.06.030 CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Ramalho de Oliveira D, Brummel AR, Miller DB. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm. 2010;16(3):185–95. doi: https://doi.org/10.18553/jmcp.2010.16.3.185 CrossRefPubMedGoogle Scholar
  43. 43.
    Carter BL, Ardery G, Dawson JD, James PA, Bergus GR, Doucette WR, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169(21):1996–2002. doi: https://doi.org/10.1001/archinternmed.2009.358 CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Nelson K, Pitaro M, Tzellas A, Lum A. Practice profile. Transforming the role of medical assistants in chronic disease management. Health Aff (Millwood). 2010;29(5):963–5. doi: https://doi.org/10.1377/hlthaff.2010.0129 CrossRefGoogle Scholar
  45. 45.
    Massimi A, De Vito C, Brufola I, Corsaro A, Marzuillo C, Migliara G, et al. Are community-based nurse-led self-management support interventions effective in chronic patients? Results of a systematic review and meta-analysis. PloS One. 2017;12(3):e0173617. doi: https://doi.org/10.1371/journal.pone.0173617 CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Weeks G, George J, Maclure K, Stewart D. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. Cochrane Database Syst Rev. 2016;11:CD011227. doi: https://doi.org/10.1002/14651858.CD011227.pub2 CrossRefPubMedGoogle Scholar

Copyright information

© Society of General Internal Medicine (This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply) 2019

Authors and Affiliations

  • Tannaz Moin
    • 1
    • 2
    Email author
  • O. Kenrik Duru
    • 1
  • Norman Turk
    • 1
  • Janet S. Chon
    • 1
  • Dominick L. Frosch
    • 3
  • Jacqueline M. Martin
    • 1
  • Kia Skrine Jeffers
    • 1
  • Yelba Castellon-Lopez
    • 1
  • Chi-Hong Tseng
    • 1
  • Keith Norris
    • 1
  • Carol M. Mangione
    • 1
    • 4
  1. 1.David Geffen School of Medicine University of CaliforniaLos AngelesUSA
  2. 2.VA Greater Los Angeles Health System and HSR&D Center for the Study of Healthcare Innovation, Implementation & PolicyLos AngelesUSA
  3. 3.Palo Alto Medical Foundation Research InstitutePalo AltoUSA
  4. 4.Jonathan and Karin Fielding School of Public HealthUniversity of CaliforniaLos AngelesUSA

Personalised recommendations